CellWell record HH-147341
Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3-4 CKD Using the 2021 CKD-EPI Equations
Nurulamin Abu Bakar; Nurul Izzati Hamzan; Siti Nurwani Ahmad Ridzuan; Izatus Shima Taib; Zariyantey Abdul Hamid; Anasufiza Habib; Noor Hafizah Hassan
2026
In plain language
Creatinine, cystatin C, and β2-microglobulin demonstrated high discriminatory ability for distinguishing moderate from severe chronic kidney disease within CKD-EPI framework.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-147341
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.